Quarterly
Annual
| Unit: USD | 2019-03-31 | 2018-12-31 |
|---|---|---|
collaboration revenue | 4,350,000 | |
operating expenses: | ||
research and development | 7,324,000 | |
general and administrative | 3,534,000 | |
total operating expenses | 10,858,000 | |
net income from operations | -6,508,000 | |
income from equity-method investment | -288,000 | |
finance income | -88,000 | |
net income | -6,884,000 | |
yoy | ||
qoq | ||
net income margin % | ||
net income per share | -0.68 | |
weighted-average shares outstanding, basic and diluted | 10,095 | |
comprehensive loss: | ||
unrealized loss on short-term investments | ||
comprehensive loss | -6,884 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.